Why the study?
Optimised use of kidney function information might improve cardiac risk prediction in noncardiac surgery.
Does continuous preoperative eGFR predict 30-day cardiac events in patients ≥45 years old undergoing nonurgent inpatient noncardiac surgery?
Does continuous preoperative eGFR predict 30-day cardiac events in patients ≥45 years old undergoing nonurgent inpatient noncardiac surgery?
Continuous preoperative eGFR is among the best cardiac risk predictors in noncardiac surgery and its inclusion would improve perioperative risk calculators.
Answers are grounded in this paper and cite their sources.
Continuous preoperative eGFR may refine perioperative cardiac risk assessment; extends existing models yet requires prospective validation.
BACKGROUND: Optimised use of kidney function information might improve cardiac risk prediction in noncardiac surgery. METHODS: In 35,815 patients from the VISION cohort study and 9219 patients from the POISE-2 trial who were ≥45 yr old and underwent nonurgent inpatient noncardiac surgery, we examined (by age and sex) the association between continuous nonlinear preoperative estimated glomerular filtration rate (eGFR) and the composite of myocardial injury after noncardiac surgery, nonfatal cardiac arrest, or death owing to a cardiac cause within 30 days after surgery. We estimated contributions of predictive information, C-statistic, and net benefit from eGFR and other common patient and surgical characteristics to large multivariable models. RESULTS: =0.79). eGFR contributed the most predictive information and mean net benefit of all predictors in both studies, most C-statistic in VISION, and third most C-statistic in POISE-2. CONCLUSIONS: Continuous preoperative eGFR is among the best cardiac risk predictors in noncardiac surgery of the large set examined. Along with its interaction with age, preoperative eGFR would improve risk calculators. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT00512109 (VISION) and NCT01082874 (POISE-2).
No takes yet. Share an insight, caveat, or question.
Roshanov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: